The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10-16 years (Q34152234)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10-16 years	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10-16 years (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

2

object named as

Cecily Banura

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Florence Mirembe

4

object named as

Florence M Mirembe

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Miriam Nakalembe

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Proscovia B Namujju

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Infectious Agents and Cancer

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

No difference in sexual behavior of adolescent girls following Human Papilloma Virus vaccination: a case study two districts in Uganda; Nakasongola and Luwero

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Self-reported sexual behaviour among adolescent girls in Uganda: reliability of data debated

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Worldwide burden of cervical cancer in 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Sexual behavior, knowledge and information sources of very young adolescents in four sub-Saharan African countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Introducing human papillomavirus vaccines - questions remain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Chapter 8: Screening for cervical cancer in developing countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158334

5 July 2018

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

1 reference

https://api.crossref.org/works/10.1186%2F1750-9378-9-29

21 January 2018

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1186%2F1750-9378-9-29

21 January 2018

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

1 reference

https://api.crossref.org/works/10.1186%2F1750-9378-9-29

21 January 2018

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant

1 reference

https://api.crossref.org/works/10.1186%2F1750-9378-9-29

21 January 2018

Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.

1 reference

https://api.crossref.org/works/10.1186%2F1750-9378-9-29

21 January 2018

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins

1 reference

https://api.crossref.org/works/10.1186%2F1750-9378-9-29

21 January 2018

Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 –- conclusions and recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25206925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

1 reference

https://pubmed.ncbi.nlm.nih.gov/25206925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beyond validity and reliability: meaning-in-context of adolescents' self-reports of sexual behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/25206925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1750-9378-9-29

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34152234&oldid=2196315743"